Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies

BACKGROUND: Chile was severely affected by COVID19 outbreaks but was also one of the first countries to start a nationwide program to vaccinate against the disease. Furthermore, Chile became one of the fastest countries to inoculate a high percentage of the target population and implemented homologo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vargas, Leonardo, Valdivieso, Nicolás, Tempio, Fabián, Simon, Valeska, Sauma, Daniela, Valenzuela, Lucía, Beltrán, Caroll, Castillo-Delgado, Loriana, Contreras-Benavides, Ximena, Acevedo, Mónica L., Acevedo, Johanna, Gonzalez, Rafael I., Valiente-Echeverría, Fernando, Soto-Rifo, Ricardo, Rosemblatt, Mario, Lopez, Mercedes, Osorio, Fabiola, Bono, María Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177225/
https://www.ncbi.nlm.nih.gov/pubmed/35676738
http://dx.doi.org/10.1186/s12916-022-02406-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177225/
https://www.ncbi.nlm.nih.gov/pubmed/35676738
http://dx.doi.org/10.1186/s12916-022-02406-0

Ejemplares similares